"Acute Coronary Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
Descriptor ID |
D054058
|
MeSH Number(s) |
C14.280.647.124 C14.907.585.124
|
Concept/Terms |
Acute Coronary Syndrome- Acute Coronary Syndrome
- Acute Coronary Syndromes
- Coronary Syndrome, Acute
- Coronary Syndromes, Acute
- Syndrome, Acute Coronary
- Syndromes, Acute Coronary
|
Below are MeSH descriptors whose meaning is more general than "Acute Coronary Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Acute Coronary Syndrome".
This graph shows the total number of publications written about "Acute Coronary Syndrome" by people in this website by year, and whether "Acute Coronary Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2011 | 2 | 0 | 2 |
2012 | 4 | 0 | 4 |
2013 | 5 | 0 | 5 |
2014 | 3 | 1 | 4 |
2015 | 2 | 1 | 3 |
2016 | 5 | 1 | 6 |
2017 | 8 | 1 | 9 |
2018 | 6 | 1 | 7 |
2019 | 5 | 0 | 5 |
2020 | 3 | 0 | 3 |
2021 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
2023 | 3 | 0 | 3 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acute Coronary Syndrome" by people in Profiles.
-
Reply: Decoding Ticagrelor Dyspnea: Central Apnea Screening Before Drug Discontinuation. JACC Cardiovasc Interv. 2024 Feb 12; 17(3):452-453.
-
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. Circulation. 2023 06 20; 147(25):1933-1944.
-
Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia. Int J Antimicrob Agents. 2023 Apr; 61(4):106752.
-
Switching Between Intravenous and Oral P2Y12 Inhibition: Easier Said Than Done. JACC Cardiovasc Interv. 2023 01 09; 16(1):47-49.
-
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022 08 11; 8(5):492-502.
-
Comparison of the effect of Morphine and Fentanyl in patients with acute coronary syndrome receiving Ticagrelor - The COMET (Comparison Morphine, Fentayl and Ticagrelor) randomized controlled trial. Int J Cardiol. 2021 05 01; 330:1-6.
-
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration. Cardiovasc Drugs Ther. 2021 04; 35(2):309-320.
-
Extending the aspirin-free paradigm to patients with acute coronary syndrome: is it time to change guidelines? EuroIntervention. 2020 Oct 23; 16(8):620-622.
-
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. Eur Heart J. 2020 10 01; 41(37):3533-3545.
-
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study. Clin Res Cardiol. 2020 Jun; 109(6):725-734.